121326339	121326339	CD	B-NP	O
|	|	NN	I-NP	O
NHH	NHH	NN	I-NP	O
|	|	NN	I-NP	O
03302120	03302120	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
061986	061986	CD	B-NP	O
|	|	CC	I-NP	O
9/25/2000	9/25/2000	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Summary	Summary	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
7/23/2000	7/23/2000	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
PRINCIPAL	PRINCIPAL	NNP	B-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
Right	Right	RB	B-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
cellulitis	cellulitis	NN	I-NP	O
.	.	.	O	O

Type	Type	NN	B-NP	O
II	II	CD	I-NP	O
diabetes	diabete	NNS	I-NP	O
mellitus	mellitus	NN	I-NP	O
.	.	.	O	O

Peripheral	Peripheral	JJ	B-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

Congestive	Congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

Hypertension	Hypertension	NN	B-NP	O
.	.	.	O	O

Chronic	Chronic	JJ	B-NP	O
abdominal	abdominal	JJ	I-NP	O
distention	distention	NN	I-NP	O
.	.	.	O	O

Chronic	Chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
.	.	.	O	O

Status	Status	NNP	B-NP	O
post	post	NN	I-NP	O
left	leave	VBD	B-VP	O
femoral	femoral	JJ	B-NP	O
popliteal	popliteal	JJ	I-NP	O
bypass	bypass	NN	I-NP	O
in	in	IN	B-PP	O
1997	1997	CD	B-NP	O
.	.	.	O	O

Status	Status	NNP	B-NP	O
post	post	NN	I-NP	O
skin	skin	NN	I-NP	O
graft	graft	NN	I-NP	O
on	on	IN	B-PP	O
right	right	JJ	B-NP	O
heel	heel	NN	I-NP	O
for	for	IN	B-PP	O
diabetic	diabetic	JJ	B-NP	O
ulcers	ulcer	NNS	I-NP	O
in	in	IN	B-PP	O
1997	1997	CD	B-NP	O
.	.	.	O	O

Coronary	Coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

Status	Status	NNP	B-NP	O
post	post	VBD	B-VP	O
open	open	JJ	B-NP	O
reduction	reduction	NN	I-NP	O
internal	internal	JJ	I-NP	O
fixation	fixation	NN	I-NP	O
left	leave	VBD	B-VP	O
ankle	ankle	NN	B-NP	O
.	.	.	O	O

Spondylolothesis	Spondylolothesis	NN	B-NP	O
.	.	.	O	O

Hypercholesterolemia	Hypercholesterolemia	NN	B-NP	O
.	.	.	O	O

Peripheral	Peripheral	JJ	B-NP	O
neuropathy	neuropathy	NN	I-NP	O
.	.	.	O	O

Diabetic	Diabetic	JJ	B-NP	O
gastroparesis	gastroparesis	NN	I-NP	O
.	.	.	O	O

Diabetic	Diabetic	JJ	B-NP	O
retinopathy	retinopathy	NN	I-NP	O
.	.	.	O	O

Carpal	Carpal	JJ	B-NP	O
tunnel	tunnel	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
.	.	.	O	O

Anemia	Anemia	NNP	B-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
Ms.	Ms.	NNP	B-NP	O
Tyrone	Tyrone	NNP	I-NP	O
Soldner	Soldner	NNP	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
66	66	CD	I-NP	O
year-old	year-old	JJ	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
type	type	NN	B-NP	O
II	II	CD	I-NP	O
diabetes	diabete	NNS	I-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
peripheral	peripheral	JJ	B-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
who	who	WP	B-NP	O
presents	present	VBZ	B-VP	O
to	to	TO	B-PP	O
us	us	PRP	B-NP	O
with	with	IN	B-PP	O
right	right	JJ	B-NP	O
leg	leg	NN	I-NP	O
swelling	swelling	NN	I-NP	O
,	,	,	O	O
pain	pain	NN	B-NP	O
and	and	CC	O	O
tenderness	tenderness	NN	B-NP	O
times	time	NNS	I-NP	O
2-3	2-3	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
last	last	JJ	B-ADJP	O
discharged	discharge	VBN	B-VP	O
from	from	IN	B-PP	O
A	A	NNP	B-NP	O
De	De	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
for	for	IN	B-PP	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
and	and	CC	O	O
chronic	chronic	JJ	B-NP	O
abdominal	abdominal	JJ	I-NP	O
distention	distention	NN	I-NP	O
on	on	IN	B-PP	O
November	November	NNP	B-NP	O
,	,	,	O	O
2000	2000	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
usual	usual	JJ	I-NP	O
state	state	NN	I-NP	O
of	of	IN	B-PP	O
poor	poor	JJ	B-NP	O
health	health	NN	I-NP	O
until	until	IN	B-PP	O
three	three	CD	B-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
noted	note	VBD	B-VP	O
an	an	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Two	Two	CD	B-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
she	she	PRP	B-NP	O
noted	note	VBD	B-VP	O
fever	fever	NN	B-NP	O
,	,	,	O	O
increased	increase	VBN	B-NP	O
abdominal	abdominal	JJ	I-NP	O
distention	distention	NN	I-NP	O
and	and	CC	O	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
noted	note	VBD	B-VP	O
rash	rash	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
presentation	presentation	NN	B-NP	O
which	which	WDT	B-NP	O
had	have	VBD	B-VP	O
rapidly	rapidly	RB	I-VP	O
progressed	progress	VBN	I-VP	O
over	over	IN	B-PP	O
one	one	CD	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
extending	extend	VBG	B-VP	O
from	from	IN	B-PP	O
heel	heel	NN	B-NP	O
to	to	TO	B-VP	O
knee	knee	VB	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
not	not	RB	I-VP	O
been	be	VBN	I-VP	O
walking	walk	VBG	I-VP	O
for	for	IN	B-PP	O
four	four	CD	B-NP	O
days	day	NNS	I-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
swelling	swell	VBG	B-VP	O
in	in	IN	B-PP	O
bilateral	bilateral	JJ	B-NP	O
legs	leg	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denies	deny	VBZ	B-VP	O
chest	ch	JJS	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
dyspnea	dyspnea	NN	B-NP	O
,	,	,	O	O
constipation	constipation	NN	B-NP	O
,	,	,	O	O
diarrhea	diarrhea	NN	B-NP	O
,	,	,	O	O
orthopnea	orthopnea	NN	B-NP	O
,	,	,	O	O
PND	PND	NN	B-NP	B-protein
,	,	,	O	O
nocturia	nocturia	NN	B-NP	O
,	,	,	O	O
melena	melena	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
keep	keep	VB	I-VP	O
track	track	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
own	own	JJ	I-NP	O
weight	weight	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
last	last	JJ	I-NP	O
bowel	bowel	NN	I-NP	O
movement	movement	NN	I-NP	O
was	be	VBD	B-VP	O
one	one	CD	B-NP	O
day	day	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
normal	normal	JJ	B-NP	O
brown	brown	NN	I-NP	O
,	,	,	O	O
slightly	slightly	RB	B-ADJP	O
loose	loose	JJ	I-ADJP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Significant	Significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
.	.	.	O	O

coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
stress	stress	NN	I-NP	O
test	test	NN	I-NP	O
in	in	IN	B-PP	O
1994	1994	CD	B-NP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
anterior	anterior	JJ	B-NP	O
ischemia	ischemia	NN	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
fixed	fixed	JJ	I-NP	O
defects	defect	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
echo	echo	NN	I-NP	O
in	in	IN	B-PP	O
July	July	NNP	B-NP	O
,	,	,	O	O
1997	1997	CD	B-NP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
left	left	JJ	B-NP	O
ventricular	ventricular	JJ	I-NP	O
hypertrophy	hypertrophy	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	O
of	of	IN	B-PP	O
55	55	CD	B-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
minor	minor	JJ	B-NP	O
inferior	inferior	JJ	I-NP	O
hypokinesis	hypokinesis	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Congestive	Congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Type	Type	NN	B-NP	O
II	II	CD	I-NP	O
diabetes	diabete	NNS	I-NP	O
mellitus	mellitus	NN	I-NP	O
.	.	.	O	O

Last	Last	JJ	B-NP	O
hemoglobin	hemoglobin	NN	I-NP	O
A1C	A1C	NN	I-NP	O
was	be	VBD	B-VP	O
9.5	9.5	CD	B-NP	O
in	in	IN	B-PP	O
September	September	NNP	B-NP	O
,	,	,	O	O
2000	2000	CD	B-NP	O
.	.	.	O	O

Complications	Complication	NNS	B-NP	O
include	include	VBP	B-VP	O
peripheral	peripheral	JJ	B-NP	O
neuropathy	neuropathy	NN	I-NP	O
,	,	,	O	O
retinopathy	retinopathy	NN	B-NP	O
,	,	,	O	O
nephropathy	nephropathy	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
baseline	baseline	NN	I-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
1.3	1.3	CD	B-NP	O
to	to	TO	B-PP	O
1.9	1.9	CD	B-NP	O
and	and	CC	O	O
diabetic	diabetic	JJ	B-NP	O
gastroparesis	gastroparesis	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Hypercholesterolemia	Hypercholesterolemia	NN	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Chronic	Chronic	JJ	B-NP	O
low	low	JJ	I-NP	O
back	back	JJ	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Chronic	Chronic	JJ	B-NP	O
constipation	constipation	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Anemia	Anemia	NNP	B-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Peripheral	Peripheral	JJ	B-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
left	leave	VBD	B-VP	O
femoral	femoral	JJ	B-NP	O
popliteal	popliteal	JJ	I-NP	O
bypass	bypass	NN	I-NP	O
in	in	IN	B-PP	O
1997	1997	CD	B-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Status	Status	NNP	B-NP	O
post	post	VBD	B-VP	O
right	right	JJ	B-NP	O
heel	heel	NN	I-NP	O
skin	skin	NN	I-NP	O
graft	graft	NN	I-NP	O
for	for	IN	B-PP	O
ulcer	ulcer	NN	B-NP	O
in	in	IN	B-PP	O
1997	1997	CD	B-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Carpal	Carpal	JJ	B-NP	O
tunnel	tunnel	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
release	release	NN	I-NP	O
in	in	IN	B-PP	O
1998	1998	CD	B-NP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

History	History	NN	B-NP	O
of	of	IN	B-PP	O
Azotobacter	Azotobacter	NN	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
in	in	IN	B-PP	O
1997	1997	CD	B-NP	O
.	.	.	O	O

12	12	CD	B-NP	O
.	.	.	O	O

Status	Status	NNP	B-NP	O
post	post	NN	I-NP	O
cholecystectomy	cholecystectomy	NN	I-NP	O
.	.	.	O	O

13	13	CD	B-NP	O
.	.	.	O	O

History	History	NN	B-NP	O
of	of	IN	B-PP	O
C.	C.	NNP	B-NP	O
difficile	difficile	JJ	I-NP	O
colitis	colitis	NN	I-NP	O
.	.	.	O	O

14	14	CD	B-NP	O
.	.	.	O	O

Status	Status	NNP	B-NP	O
left	leave	VBD	B-VP	O
ankle	ankle	JJ	B-NP	O
fracture	fracture	NN	I-NP	O
open	open	JJ	I-NP	O
reduction	reduction	NN	I-NP	O
internal	internal	JJ	I-NP	O
fixation	fixation	NN	I-NP	O
in	in	IN	B-PP	O
February	February	NNP	B-NP	O
,	,	,	O	O
1998	1998	CD	B-NP	O
.	.	.	O	O

MEDICATION	MEDICATION	NN	B-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
include	include	VBP	B-VP	O
Insulin	Insulin	NN	B-NP	B-protein
NPH	NPH	NN	I-NP	I-protein
pork	pork	NN	I-NP	I-protein
45	45	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
q	q	NN	I-NP	I-protein
a.m.	a.m.	RB	B-ADVP	O
,	,	,	O	O
8	8	CD	B-NP	O
units	unit	NNS	I-NP	O
q	q	NN	I-NP	O
p.m.	p.m.	RB	B-ADVP	O
,	,	,	O	O
Lopressor	Lopressor	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
Vaseretic	Vaseretic	NNP	B-NP	O
10/25	10/25	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
Dulcolax	Dulcolax	NNP	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
aspirin	aspirin	NN	B-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
Senokot	Senokot	NNP	B-NP	O
2	2	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
Diazepam	Diazepam	NNP	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
Lipitor	Lipitor	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
lactulose	lactulose	RB	B-NP	O
30	30	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
Neurontin	Neurontin	NN	B-NP	B-protein
300	300	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
t.i.d.	t.i.d.	NN	I-NP	I-protein
,	,	,	O	O
Naprosyn	Naprosyn	NNP	B-NP	O
p.r.n.	p.r.n.	NNP	I-NP	O
ALLERGIES	ALLERGIES	NNPS	I-NP	O
:	:	:	O	O
Include	Include	NNP	B-NP	O
Aldomet	Aldomet	NNP	I-NP	O
,	,	,	O	O
nifedipine	nifedipine	NN	B-NP	O
,	,	,	O	O
darvocet	darvocet	NN	B-NP	O
which	which	WDT	B-NP	O
makes	make	VBZ	B-VP	O
her	her	PRP	B-NP	O
drowsy	drowsy	NN	I-NP	O
,	,	,	O	O
Percocet	Percocet	NNP	B-NP	O
which	which	WDT	B-NP	O
makes	make	VBZ	B-VP	O
her	her	PRP$	B-NP	O
vomit	vomit	NN	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
lives	live	VBZ	B-VP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
sister	sister	NN	I-NP	O
in	in	IN	B-PP	O
Morp	Morp	NNP	B-NP	O
Dr	Dr	NNP	I-NP	O
The	The	DT	B-NP	O
son	son	NN	I-NP	O
is	be	VBZ	B-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
care	care	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
smoking	smoking	NN	B-NP	O
or	or	CC	I-NP	O
drinking	drinking	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
husband	husband	NN	I-NP	O
died	die	VBD	B-VP	O
a	a	DT	B-NP	O
year	year	NN	I-NP	O
ago	ago	IN	B-ADVP	O
of	of	IN	B-PP	O
complications	complication	NNS	B-NP	O
from	from	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
bypass	bypass	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
Vital	Vital	JJ	B-NP	O
signs	sign	NNS	I-NP	O
:	:	:	O	O
Temperature	Temperature	NN	B-NP	O
102.1	102.1	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
148/68	148/68	CD	I-NP	O
,	,	,	O	O
pulse	pulse	NN	B-NP	O
84	84	CD	I-NP	O
,	,	,	O	O
respirations	respiration	NNS	B-NP	O
22	22	CD	B-NP	O
,	,	,	O	O
sating	sate	VBG	B-VP	O
92	92	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
two	two	CD	B-NP	O
liters	liter	NNS	I-NP	O
.	.	.	O	O

General	General	JJ	B-NP	O
examination	examination	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
obese	obese	JJ	I-NP	O
woman	woman	NN	I-NP	O
lying	lie	VBG	B-VP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
30	30	CD	I-NP	O
degree	degree	NN	I-NP	O
angle	angle	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
bed	bed	NN	I-NP	O
,	,	,	O	O
pleasant	pleasant	NN	B-NP	O
and	and	CC	B-PP	O
not	not	RB	B-PP	O
in	in	IN	I-PP	O
acute	acute	JJ	B-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

Head	Head	NN	B-NP	O
and	and	CC	I-NP	O
neck	neck	NN	I-NP	O
examination	examination	NN	I-NP	O
was	be	VBD	B-VP	O
benign	benign	JJ	B-ADJP	O
.	.	.	O	O

Lungs	Lung	NNS	B-NP	O
have	have	VBP	B-VP	O
rales	rale	NNS	B-NP	O
up	up	IN	B-PP	O
one-third	one-third	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
lungs	lung	NNS	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
,	,	,	O	O
no	no	DT	B-NP	O
wheezes	wheeze	NNS	I-NP	O
or	or	CC	I-NP	O
rhonchi	rhonchus	NNS	I-NP	O
.	.	.	O	O

Heart	Heart	NN	B-NP	O
regular	regular	JJ	I-NP	O
rate	rate	NN	I-NP	O
and	and	CC	O	O
rhythm	rhythm	NN	B-NP	O
,	,	,	O	O
S1	S1	NN	B-NP	B-protein
,	,	,	O	O
S2	S2	NN	B-NP	B-protein
with	with	IN	B-PP	O
S3	S3	NN	B-NP	B-protein
and	and	CC	I-NP	O
II/VI	II/VI	NN	I-NP	O
systolic	systolic	JJ	I-NP	O
murmur	murmur	NN	I-NP	O
,	,	,	O	O
best	good	JJS	B-NP	O
heard	hear	VBD	B-VP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
base	base	NN	I-NP	O
.	.	.	O	O

Jugular	Jugular	JJ	B-NP	O
venous	venous	JJ	I-NP	O
pulsation	pulsation	NN	I-NP	O
at	at	IN	B-PP	O
11	11	CD	B-NP	O
cm	cm	NN	I-NP	O
.	.	.	O	O

Abdominal	Abdominal	JJ	B-NP	O
examination	examination	NN	I-NP	O
was	be	VBD	B-VP	O
soft	soft	JJ	B-ADJP	O
,	,	,	O	O
nontender	nontender	JJ	B-ADJP	O
,	,	,	O	O
mildly	mildly	RB	B-VP	O
distended	distend	VBN	I-VP	O
,	,	,	O	O
no	no	DT	B-NP	O
mass	mass	NN	I-NP	O
and	and	CC	O	O
normal	normal	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
showed	show	VBD	B-VP	O
diffuse	diffuse	JJ	B-NP	O
erythema	erythema	NN	I-NP	O
from	from	IN	B-PP	O
right	right	JJ	B-NP	O
heel	heel	NN	I-NP	O
extending	extend	VBG	B-VP	O
to	to	TO	B-PP	O
5	5	CD	B-NP	O
cm	cm	NN	I-NP	O
below	below	IN	B-PP	O
the	the	DT	B-NP	O
knee	knee	NN	I-NP	O
,	,	,	O	O
mild	mild	JJ	B-NP	O
tenderness	tenderness	NN	I-NP	O
,	,	,	O	O
edema	edema	NN	B-NP	O
greater	great	JJR	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
leg	leg	NN	I-NP	O
than	than	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
leg	leg	NN	I-NP	O
.	.	.	O	O

3	3	CD	B-NP	O
+	+	SYM	I-NP	O
pitting	pit	VBG	I-NP	O
edema	edema	NN	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
5	5	CD	I-NP	O
cm	cm	NN	I-NP	O
x	x	SYM	B-NP	O
5	5	CD	B-NP	O
cm	cm	NN	I-NP	O
skin	skin	NN	I-NP	O
graft	graft	NN	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
heel	heel	NN	I-NP	O
with	with	IN	B-PP	O
some	some	DT	B-NP	O
skin	skin	NN	I-NP	O
breakdown	breakdown	NN	I-NP	O
around	around	IN	B-PP	O
the	the	DT	B-NP	O
graft	graft	NN	I-NP	B-DNA
site	site	NN	I-NP	I-DNA
,	,	,	O	O
slightly	slightly	RB	B-ADJP	O
weepy	weepy	JJ	I-ADJP	O
,	,	,	O	O
no	no	DT	B-NP	O
pus	pus	NN	I-NP	O
.	.	.	O	O

Neurologic	Neurologic	JJ	B-NP	O
examination	examination	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
alert	alert	JJ	B-ADJP	O
and	and	CC	O	O
oriented	orient	VBN	B-VP	O
times	time	NNS	B-NP	O
three	three	CD	B-NP	O
.	.	.	O	O

Cranial	Cranial	JJ	B-NP	O
nerves	nerve	NNS	I-NP	O
are	be	VBP	B-VP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
any	any	DT	B-NP	O
sensation	sensation	NN	I-NP	O
in	in	IN	B-PP	O
bilateral	bilateral	JJ	B-NP	O
legs	leg	NNS	I-NP	O
.	.	.	O	O

Normal	Normal	JJ	B-NP	O
strength	strength	NN	I-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
Significant	Significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
hematocrit	hematocrit	NN	B-NP	O
of	of	IN	B-PP	O
30.7	30.7	CD	B-NP	O
,	,	,	O	O
white	white	JJ	B-NP	O
blood	blood	NN	I-NP	O
count	count	NN	I-NP	O
10	10	CD	I-NP	O
,	,	,	I-NP	O
340	340	CD	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
differential	differential	NN	I-NP	O
of	of	IN	B-PP	O
76	76	CD	B-NP	O
polys	poly	NNS	I-NP	O
,	,	,	O	O
14	14	CD	B-NP	O
bands	band	NNS	I-NP	O
,	,	,	O	O
5	5	CD	B-NP	O
lymphocytes	lymphocyte	NNS	I-NP	O
.	.	.	O	O

Chem-7	Chem-7	NN	B-NP	B-protein
was	be	VBD	B-VP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
creatinine	creatinine	NN	B-NP	O
of	of	IN	B-PP	O
1.8	1.8	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
liver	liver	NN	I-NP	O
function	function	NN	I-NP	O
tests	test	NNS	I-NP	O
were	be	VBD	B-VP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
range	range	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
CK	CK	NN	I-NP	O
first	first	JJ	I-NP	O
set	set	NN	I-NP	O
was	be	VBD	B-VP	O
120	120	CD	B-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
MB	MB	NN	I-NP	O
of	of	IN	B-PP	O
2.6	2.6	CD	B-NP	O
and	and	CC	O	O
troponin	troponin	NN	B-NP	O
of	of	IN	B-PP	O
1.39	1.39	CD	B-NP	O
,	,	,	O	O
coags	coag	VBZ	B-VP	O
normal	normal	JJ	B-NP	O
D-dimer	D-dimer	NN	I-NP	O
of	of	IN	B-PP	O
greater	great	JJR	B-NP	O
than	than	IN	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
010	010	CD	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
urinalysis	urinalysis	NN	I-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Electrocardiogram	Electrocardiogram	NN	B-NP	O
showed	show	VBD	B-VP	O
1	1	CD	B-NP	O
mm	mm	NN	I-NP	O
ST	ST	NN	I-NP	O
depression	depression	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
lateral	lateral	JJ	I-NP	O
leads	lead	NNS	I-NP	O
,	,	,	O	O
unchanged	unchanged	JJ	B-ADJP	O
from	from	IN	B-PP	O
baseline	baseline	NN	B-NP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
revealed	reveal	VBD	B-VP	O
bilateral	bilateral	JJ	B-NP	O
interstitial	interstitial	JJ	I-NP	O
prominence	prominence	NN	I-NP	O
,	,	,	O	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
focal	focal	JJ	I-NP	O
opacities	opacity	NNS	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
PROBLEM	PROBLEM	NN	B-NP	B-protein
#	#	#	B-NP	I-protein
1	1	CD	I-NP	I-protein
,	,	,	O	O
CELLULITIS	CELLULITIS	NN	B-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
cefazolin	cefazolin	NN	B-NP	O
and	and	CC	I-NP	O
Flagyl	Flagyl	NN	I-NP	O
for	for	IN	B-PP	O
broad	broad	JJ	B-NP	O
coverage	coverage	NN	I-NP	O
of	of	IN	B-PP	O
cellulitis	cellulitis	NN	B-NP	O
given	give	VBN	B-VP	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
levofloxacin	levofloxacin	NN	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
hospital	hospital	NN	B-NP	O
day	day	NN	I-NP	O
#	#	#	B-NP	O
2	2	CD	I-NP	O
to	to	TO	B-VP	O
cover	cover	VB	I-VP	O
gram	gram	NN	B-NP	O
negative	negative	JJ	I-NP	O
organisms	organism	NNS	I-NP	O
.	.	.	O	O

Blood	Blood	NN	B-NP	O
cultures	culture	NNS	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
are	be	VBP	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Because	Because	IN	B-PP	O
of	of	IN	I-PP	O
the	the	DT	B-NP	O
skin	skin	NN	I-NP	O
graft	graft	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
right	right	JJ	I-NP	O
heel	heel	NN	I-NP	O
,	,	,	O	O
plastic	plastic	NN	B-NP	O
surgery	surgery	NN	I-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
to	to	TO	I-VP	O
assess	assess	VB	I-VP	O
the	the	DT	B-NP	O
integrity	integrity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
skin	skin	NN	I-NP	O
graft	graft	NN	I-NP	O
.	.	.	O	O

They	They	PRP	B-NP	O
concluded	conclude	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
skin	skin	NN	I-NP	O
graft	graft	NN	I-NP	O
is	be	VBZ	B-VP	O
intact	intact	JJ	B-ADJP	O
and	and	CC	O	O
the	the	DT	B-NP	O
source	source	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cellulitis	cellulitis	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
heel	heel	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
hospital	hospital	NN	B-NP	O
day	day	NN	I-NP	O
#	#	#	B-NP	O
3	3	CD	I-NP	O
,	,	,	O	O
Flagyl	Flagyl	NN	B-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
because	because	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
could	could	MD	B-VP	O
not	not	RB	I-VP	O
tolerate	tolerate	VB	I-VP	O
oral	oral	JJ	B-NP	O
sores	sore	NNS	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
GI	GI	NN	I-NP	O
upset	upset	NN	I-NP	O
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
elected	elect	VBD	B-VP	O
to	to	TO	I-VP	O
change	change	VB	I-VP	O
the	the	DT	B-NP	O
antibiotic	antibiotic	JJ	I-NP	O
regimen	regimen	NN	I-NP	O
to	to	TO	B-PP	O
Clindamycin	Clindamycin	NN	B-NP	O
and	and	CC	I-NP	O
levofloxacin	levofloxacin	NN	I-NP	O
.	.	.	O	O

cefazolin	cefazolin	NN	B-NP	O
and	and	CC	I-NP	O
Flagyl	Flagyl	NN	I-NP	O
were	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
.	.	.	O	O

On	On	IN	B-PP	O
hospital	hospital	NN	B-NP	O
day	day	NN	I-NP	O
#	#	#	B-NP	O
6	6	CD	I-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
developed	develop	VBD	B-VP	O
diarrhea	diarrhea	NN	B-NP	O
.	.	.	O	O

Given	Give	VBN	B-PP	O
her	her	PRP$	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
C.	C.	NNP	B-NP	O
difficile	difficile	NNP	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
lack	lack	NN	I-NP	O
of	of	IN	B-PP	O
improvement	improvement	NN	B-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
cellulitis	cellulitis	NN	I-NP	O
,	,	,	O	O
Infectious	Infectious	JJ	B-NP	O
Disease	Disease	NN	I-NP	O
were	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
.	.	.	O	O

We	We	PRP	B-NP	O
started	start	VBD	B-VP	O
cefotaxime	cefotaxime	NN	B-NP	O
and	and	CC	I-NP	O
Vancomycin	Vancomycin	NN	I-NP	O
on	on	IN	B-PP	O
hospital	hospital	NN	B-NP	B-protein
day	day	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
7	7	CD	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
low	low	JJ	B-NP	O
grade	grade	NN	I-NP	O
temperature	temperature	NN	I-NP	O
spikes	spike	VBZ	B-VP	O
with	with	IN	B-PP	O
daily	daily	JJ	B-NP	O
blood	blood	NN	I-NP	O
cultures	culture	NNS	I-NP	O
which	which	WDT	B-NP	O
have	have	VBP	B-VP	O
all	all	DT	O	O
been	be	VBN	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Wound	Wound	JJ	B-NP	O
culture	culture	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
bullae	bullae	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
taken	take	VBN	I-VP	O
which	which	WDT	B-NP	O
has	have	VBZ	B-VP	O
also	also	RB	I-VP	O
been	be	VBN	I-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Vancomycin	Vancomycin	NN	B-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
low	low	JJ	B-NP	O
suspicions	suspicion	NNS	I-NP	O
of	of	IN	B-PP	O
resistant	resistant	JJ	B-NP	O
organisms	organism	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
LENIs	LENI	NNS	B-NP	B-protein
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
DVT	DVT	NN	B-NP	B-protein
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
foot	foot	NN	I-NP	O
film	film	NN	I-NP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
signs	sign	NNS	I-NP	O
of	of	IN	B-PP	O
osteomyelitis	osteomyelitis	NN	B-NP	O
.	.	.	O	O

Unfortunately	Unfortunately	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
cellulitis	cellulitis	NN	I-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
look	look	VB	I-VP	O
significantly	significantly	RB	B-ADJP	O
improved	improve	VBN	I-ADJP	O
.	.	.	O	O

We	We	PRP	B-NP	O
postulate	postulate	VBP	B-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
is	be	VBZ	B-VP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
combination	combination	NN	I-NP	O
of	of	IN	B-PP	O
noncompliance	noncompliance	NN	B-NP	O
with	with	IN	B-PP	O
strict	strict	JJ	B-NP	O
elevation	elevation	NN	I-NP	O
,	,	,	O	O
peripheral	peripheral	JJ	B-NP	O
edema	edema	NN	I-NP	O
from	from	IN	B-PP	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
peripheral	peripheral	JJ	B-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
and	and	CC	O	O
diabetes	diabetes	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
spike	spike	VB	I-VP	O
low	low	JJ	B-NP	O
grade	grade	NN	I-NP	O
temperatures	temperature	NNS	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
carried	carry	VBD	B-VP	O
out	out	RP	B-PRT	O
pan	pan	NN	B-NP	O
culture	culture	NN	I-NP	O
which	which	WDT	B-NP	O
have	have	VBP	B-VP	O
all	all	DT	O	O
been	be	VBN	B-VP	O
negative	negative	JJ	B-ADJP	O
so	so	RB	B-ADVP	O
far	far	RB	I-ADVP	O
including	include	VBG	B-PP	O
urine	urine	NN	B-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
dictation	dictation	NN	I-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
on	on	IN	B-PP	O
cefotaxime	cefotaxime	NN	B-NP	O
for	for	IN	B-PP	O
seven	seven	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

Infectious	Infectious	JJ	B-NP	O
Disease	Disease	NN	I-NP	O
recommends	recommend	VBZ	B-VP	O
an	an	DT	B-NP	O
MRI	MRI	NN	I-NP	O
to	to	TO	B-VP	O
rule	rule	VB	I-VP	O
out	out	RP	B-PRT	O
osteo	osteo	NN	B-NP	O
and	and	CC	O	O
deeper	deep	JJR	B-NP	O
infection	infection	NN	I-NP	O
since	since	IN	B-PP	O
the	the	DT	B-NP	O
cellulitis	cellulitis	NN	I-NP	O
is	be	VBZ	B-VP	O
very	very	RB	B-VP	O
slowly	slowly	RB	I-VP	O
improving	improve	VBG	I-VP	O
.	.	.	O	O

PROBLEM	PROBLEM	NN	B-NP	B-protein
#	#	#	B-NP	I-protein
2	2	CD	I-NP	I-protein
,	,	,	O	O
CHRONIC	CHRONIC	NNP	B-NP	O
RENAL	RENAL	NNP	I-NP	O
FAILURE	FAILURE	NNP	I-NP	O
AND	AND	NNP	I-NP	O
CHRONIC	CHRONIC	NNP	I-NP	O
RENAL	RENAL	NNP	I-NP	O
INSUFFICIENCY	INSUFFICIENCY	NNP	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
we	we	PRP	B-NP	O
started	start	VBD	B-VP	O
to	to	TO	I-VP	O
diurese	diurese	VB	I-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
as	as	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
volume	volume	NN	B-NP	O
overloaded	overload	VBN	B-VP	O
by	by	IN	B-PP	O
examination	examination	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
started	start	VBD	B-VP	O
her	her	PRP	B-NP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
outpatient	outpatient	NN	I-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
medications	medication	NNS	I-NP	O
to	to	TO	B-VP	O
control	control	VB	I-VP	O
her	her	PRP$	B-NP	O
hypertension	hypertension	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
on	on	IN	B-PP	O
hospital	hospital	NN	B-NP	O
day	day	NN	I-NP	O
#	#	#	B-NP	O
2	2	CD	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
dipped	dip	VBD	B-VP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
high	high	JJ	I-NP	O
90s	90s	CD	I-NP	O
to	to	TO	B-PP	O
100	100	CD	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
rise	rise	NN	I-NP	O
in	in	IN	B-PP	O
creatinine	creatinine	NN	B-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
withheld	withhold	VBD	B-VP	O
all	all	DT	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
medication	medication	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
diuresis	diuresis	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
climb	climb	VB	I-VP	O
from	from	IN	B-PP	O
2.2	2.2	CD	B-NP	O
to	to	TO	B-PP	O
3.3	3.3	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
urinalysis	urinalysis	NN	I-NP	O
showed	show	VBD	B-VP	O
numerous	numerous	JJ	B-NP	B-cell_type
red	red	JJ	I-NP	I-cell_type
blood	blood	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
no	no	DT	B-NP	O
eosinophils	eosinophil	NNS	I-NP	B-cell_type
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	B-cell_line
urine	urine	NN	I-NP	I-cell_line
culture	culture	NN	I-NP	I-cell_line
grew	grow	VBD	B-VP	O
out	out	RP	B-PRT	O
lactobacillus	lactobacillus	NN	B-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
treated	treat	VBN	I-VP	O
.	.	.	O	O

Renal	Renal	JJ	B-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
acute	acute	JJ	I-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
was	be	VBD	B-VP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
prerenal	prerenal	JJ	B-NP	O
causes	cause	NNS	I-NP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
drop	drop	NN	I-NP	O
in	in	IN	B-PP	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
mild	mild	JJ	B-NP	O
ATN	ATN	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
creatinine	creatinine	NN	I-NP	O
responded	respond	VBD	B-VP	O
to	to	TO	I-VP	O
gentle	gentle	VB	I-VP	O
fluid	fluid	NN	B-NP	O
boluses	bolus	NNS	I-NP	O
and	and	CC	O	O
resolved	resolve	VBN	B-VP	O
on	on	IN	B-PP	O
its	its	PRP$	B-NP	O
own	own	JJ	I-NP	O
by	by	IN	B-PP	O
hospital	hospital	NN	B-NP	B-protein
day	day	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
7	7	CD	I-NP	I-protein
.	.	.	O	O

During	During	IN	B-PP	O
the	the	DT	B-NP	O
period	period	NN	I-NP	O
of	of	IN	B-PP	O
acute	acute	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
marked	marked	JJ	B-NP	O
hyponatremia	hyponatremia	NN	I-NP	O
which	which	WDT	B-NP	O
also	also	RB	B-ADVP	O
resolved	resolve	VBD	B-VP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
renal	renal	JJ	I-NP	O
function	function	NN	I-NP	O
improved	improve	VBD	B-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
creatinine	creatinine	NN	I-NP	O
improved	improve	VBD	B-VP	O
to	to	TO	B-PP	O
1.1	1.1	CD	B-NP	O
on	on	IN	B-PP	O
hospital	hospital	NN	B-NP	O
day	day	NN	I-NP	O
#	#	#	B-NP	O
10	10	CD	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
a	a	DT	B-NP	O
CT	CT	NN	I-NP	O
with	with	IN	B-PP	O
contrast	contrast	NN	B-NP	O
to	to	TO	B-VP	O
delineate	delineate	VB	I-VP	O
a	a	DT	B-NP	O
possible	possible	JJ	I-NP	O
liver	liver	NN	I-NP	O
mass	mass	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
subsequent	subsequent	JJ	I-NP	O
creatinine	creatinine	NN	I-NP	O
climbed	climb	VBD	B-VP	O
to	to	TO	B-PP	O
1.8	1.8	CD	B-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
had	have	VBD	B-VP	O
also	also	RB	I-VP	O
started	start	VBN	I-VP	O
her	her	PRP	B-NP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
outpatient	outpatient	NN	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
enalapril	enalapril	NN	B-NP	O
and	and	CC	I-NP	O
Lasix	Lasix	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
elected	elect	VBD	B-VP	O
to	to	TO	I-VP	O
discontinue	discontinue	VB	I-VP	O
the	the	DT	B-NP	O
enalapril	enalapril	NN	I-NP	O
and	and	CC	I-NP	O
Lasix	Lasix	NN	I-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
increased	increase	VBN	I-NP	O
creatinine	creatinine	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
will	will	MD	B-VP	O
observe	observe	VB	I-VP	O
and	and	CC	I-VP	O
add	add	VB	I-VP	O
back	back	RB	B-ADVP	O
an	an	DT	B-NP	O
ace	ace	NN	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-VP	O
.	.	.	O	O

PROBLEM	PROBLEM	NN	B-NP	B-protein
#	#	#	I-NP	I-protein
3	3	CD	I-NP	I-protein
,	,	,	O	O
CORONARY	CORONARY	NNP	B-NP	O
ARTERY	ARTERY	NNP	I-NP	O
DISEASE	DISEASE	NNP	I-NP	O
,	,	,	O	O
STATUS	STATUS	NNP	B-NP	O
POST	POST	NNP	I-NP	O
NON	NON	NNP	I-NP	O
Q-WAVE	Q-WAVE	NNP	I-NP	O
MYOCARDIAL	MYOCARDIAL	NNP	I-NP	O
INFARCTION	INFARCTION	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
rule	rule	NN	I-NP	O
out	out	IN	B-PP	O
protocol	protocol	NN	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
her	her	PRP$	B-NP	O
third	third	JJ	I-NP	O
set	set	NN	I-NP	O
of	of	IN	B-PP	O
enzymes	enzyme	NNS	B-NP	B-protein
she	she	PRP	B-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
CK	CK	NN	I-NP	B-protein
of	of	IN	B-PP	O
142	142	CD	B-NP	O
,	,	,	O	O
CK	CK	NN	B-NP	B-protein
MB	MB	NN	I-NP	I-protein
of	of	IN	B-PP	O
2.2	2.2	CD	B-NP	O
but	but	CC	O	O
a	a	DT	B-NP	O
troponin	troponin	NN	I-NP	O
of	of	IN	B-PP	O
6.64	6.64	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
asymptomatic	asymptomatic	JJ	B-ADJP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
chest	chest	NN	I-NP	O
pains	pain	NNS	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
electrocardiogram	electrocardiogram	NN	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

Cardiology	Cardiology	NN	B-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
and	and	CC	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
small	small	JJ	I-NP	O
non	non	JJ	I-NP	O
Q-wave	Q-wave	JJ	I-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
troponin	troponin	NN	I-NP	O
leak	leak	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
repeat	repeat	NN	I-NP	O
echo	echo	NN	I-NP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
showed	show	VBD	B-VP	O
preserved	preserve	VBN	B-NP	O
EF	EF	NN	I-NP	O
at	at	IN	B-PP	O
55	55	CD	B-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
observable	observable	JJ	I-NP	O
wall	wall	NN	I-NP	O
motion	motion	NN	I-NP	O
abnormalities	abnormality	NNS	I-NP	O
.	.	.	O	O

As	As	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
refused	refuse	VBN	I-VP	O
catheterization	catheterization	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
decided	decide	VBN	I-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
be	be	VB	B-VP	O
managed	manage	VBN	I-VP	O
medically	medically	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Metoprolol	Metoprolol	NN	B-NP	O
12.5	12.5	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
aspirin	aspirin	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
remained	remain	VBN	I-VP	O
symptom	symptom	NN	B-ADJP	O
free	free	JJ	I-ADJP	O
.	.	.	O	O

PROBLEM	PROBLEM	NN	B-NP	B-protein
#	#	#	B-NP	I-protein
4	4	CD	I-NP	I-protein
,	,	,	O	O
HYPERTENSION	HYPERTENSION	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	B-ADVP	O
slightly	slightly	RB	B-ADJP	O
hypotensive	hypotensive	JJ	I-ADJP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
systolic	systolic	JJ	I-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
90s	90s	CD	B-NP	O
to	to	TO	B-PP	O
100	100	CD	B-NP	O
on	on	IN	B-PP	O
hospital	hospital	NN	B-NP	B-protein
day	day	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
1	1	CD	I-NP	I-protein
.	.	.	O	O

Her	Her	PRP$	B-NP	O
enalapril	enalapril	NN	I-NP	O
and	and	CC	I-NP	O
outpatient	outpatient	NN	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
Atenolol	Atenolol	NN	B-NP	O
were	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
back	back	RB	B-ADVP	O
on	on	IN	B-PP	O
Metoprolol	Metoprolol	NN	B-NP	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
non	non	JJ	I-NP	O
Q-wave	Q-wave	JJ	I-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
.	.	.	O	O

Currently	Currently	RB	B-ADVP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
is	be	VBZ	B-VP	O
maintained	maintain	VBN	I-VP	O
between	between	IN	B-PP	O
130-150	130-150	CD	B-NP	O
systolic	systolic	JJ	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
attempted	attempt	VBD	B-VP	O
to	to	TO	I-VP	O
add	add	VB	I-VP	O
back	back	JJ	B-NP	O
enalapril	enalapril	NN	I-NP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
to	to	TO	B-VP	O
preserve	preserve	VB	I-VP	O
her	her	PRP$	B-NP	O
kidney	kidney	NN	I-NP	O
function	function	NN	I-NP	O
given	give	VBN	B-VP	O
her	her	PRP$	B-NP	O
diabetes	diabetes	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
increased	increase	VBD	B-VP	O
mildly	mildly	RB	B-ADVP	O
,	,	,	O	O
thus	thus	RB	B-ADVP	O
we	we	PRP	B-NP	O
have	have	VBP	B-VP	O
elected	elect	VBN	I-VP	O
to	to	TO	I-VP	O
hold	hold	VB	I-VP	O
enalapril	enalapril	NN	B-NP	O
again	again	RB	B-ADVP	O
.	.	.	O	O

PROBLEM	PROBLEM	NN	B-NP	B-protein
#	#	#	B-NP	I-protein
5	5	CD	I-NP	I-protein
,	,	,	O	O
GASTROINTESTINAL	GASTROINTESTINAL	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
constipation	constipation	NN	I-NP	O
on	on	IN	B-PP	O
home	home	NN	B-NP	O
regimen	regimen	NN	I-NP	O
of	of	IN	B-PP	O
Dulcolax	Dulcolax	NN	B-NP	O
,	,	,	I-NP	O
senna	senna	NN	I-NP	O
,	,	,	I-NP	O
Colace	Colace	NN	I-NP	O
and	and	CC	I-NP	O
lactulose	lactulose	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
KUB	KUB	NN	I-NP	B-protein
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
air	air	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
colon	colon	NN	I-NP	O
but	but	CC	O	O
no	no	DT	B-NP	O
obstruction	obstruction	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
that	that	IN	B-SBAR	O
her	her	PRP$	B-NP	O
chronic	chronic	JJ	I-NP	O
distention	distention	NN	I-NP	O
is	be	VBZ	B-VP	O
from	from	IN	B-PP	O
diabetic	diabetic	JJ	B-NP	O
gastroparesis	gastroparesis	NN	I-NP	O
and	and	CC	O	O
relative	relative	JJ	B-NP	O
immobility	immobility	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
developed	develop	VBD	B-VP	O
diarrhea	diarrhea	NN	B-NP	O
during	during	IN	B-PP	O
her	her	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
for	for	IN	B-PP	O
which	which	WDT	B-NP	O
her	her	PRP$	B-NP	O
laxatives	laxative	NNS	I-NP	O
were	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
stool	stool	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
C.	C.	NNP	B-NP	O
difficile	difficile	VB	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
tolerated	tolerate	VBN	I-VP	O
very	very	RB	B-NP	O
little	little	JJ	I-NP	O
food	food	NN	I-NP	O
due	due	JJ	B-PP	O
to	to	TO	B-PP	O
abdominal	abdominal	JJ	B-NP	O
distention	distention	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
continued	continue	VBN	I-VP	O
to	to	TO	I-VP	O
advance	advance	VB	I-VP	O
her	her	PRP$	B-NP	O
diet	diet	NN	I-NP	O
currently	currently	RB	B-ADVP	O
to	to	TO	B-PP	O
some	some	DT	B-NP	O
small	small	JJ	I-NP	O
snacks	snack	NNS	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
laxatives	laxative	NNS	I-NP	O
were	be	VBD	B-VP	O
re-instituted	re-institute	VBN	I-VP	O
.	.	.	O	O

Because	Because	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
spike	spike	VB	I-VP	O
a	a	DT	B-NP	O
low	low	JJ	I-NP	O
grade	grade	NN	I-NP	O
temperature	temperature	NN	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
some	some	DT	B-NP	O
abnormal	abnormal	JJ	I-NP	O
liver	liver	NN	I-NP	O
function	function	NN	I-NP	O
tests	test	NNS	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
pursued	pursue	VBD	B-VP	O
a	a	DT	B-NP	O
renal	renal	JJ	I-NP	O
ultrasound	ultrasound	NN	I-NP	O
to	to	TO	B-VP	O
rule	rule	VB	I-VP	O
out	out	RP	B-PRT	O
her	her	PRP$	B-NP	O
renal	renal	JJ	I-NP	O
abscess	abscess	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
upper	upper	JJ	I-NP	O
quadrant	quadrant	JJ	I-NP	O
ultrasound	ultrasound	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
right	right	JJ	I-NP	O
upper	upper	JJ	I-NP	O
quadrant	quadrant	JJ	I-NP	O
ultrasound	ultrasound	NN	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
possible	possible	JJ	I-NP	O
liver	liver	NN	I-NP	O
mass	mass	NN	I-NP	O
for	for	IN	B-PP	O
which	which	WDT	B-NP	O
we	we	PRP	B-NP	O
ordered	order	VBD	B-VP	O
a	a	DT	B-NP	O
followup	followup	NN	I-NP	O
CT	CT	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
abdomen	abdoman	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
CT	CT	NN	I-NP	B-protein
of	of	IN	B-PP	O
the	the	DT	B-NP	O
abdomen	abdoman	NNS	I-NP	O
showed	show	VBD	B-VP	O
normal	normal	JJ	B-NP	O
variant	variant	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
shape	shape	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
liver	liver	NN	I-NP	O
,	,	,	O	O
caused	cause	VBN	B-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
bowel	bowel	NN	I-NP	O
loop	loop	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
anterior	anterior	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
liver	liver	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
unchanged	unchanged	JJ	B-ADJP	O
compared	compare	VBN	B-PP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
study	study	NN	I-NP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
in	in	IN	B-PP	O
1996	1996	CD	B-NP	O
.	.	.	O	O

PROBLEM	PROBLEM	NN	B-NP	B-protein
#	#	#	B-NP	I-protein
6	6	CD	I-NP	I-protein
,	,	,	O	O
ANEMIA	ANEMIA	NNP	B-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
slightly	slightly	RB	B-ADJP	O
anemic	anemic	JJ	I-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
of	of	IN	B-PP	O
30	30	CD	B-NP	O
.	.	.	O	O

During	During	IN	B-PP	O
her	her	PRP$	B-NP	O
past	past	JJ	I-NP	O
hospitalizations	hospitalization	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
always	always	RB	B-ADVP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
hematocrit	hematocrit	NN	I-NP	B-protein
around	around	IN	B-PP	I-protein
30	30	CD	B-NP	I-protein
.	.	.	O	O

On	On	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
her	her	PRP$	B-NP	O
stools	stool	NNS	I-NP	O
were	be	VBD	B-VP	O
trace	trace	NN	B-NP	O
guaiac	guaiac	NN	I-NP	O
positive	positive	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
received	receive	VBD	B-VP	O
two	two	CD	B-NP	O
units	unit	NNS	I-NP	O
of	of	IN	B-PP	O
packed	packed	JJ	B-NP	O
red	red	JJ	I-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
transfusion	transfusion	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
appropriate	appropriate	JJ	I-NP	O
response	response	NN	I-NP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
of	of	IN	B-PP	O
36	36	CD	B-NP	O
.	.	.	O	O

GI	GI	NN	B-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
since	since	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
further	further	JJ	I-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
decided	decide	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
would	would	MD	B-VP	O
pursue	pursue	VB	I-VP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
workup	workup	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
anemia	anemia	NN	I-NP	O
in	in	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
colonoscopy	colonoscopy	NN	B-NP	O
.	.	.	O	O

PROBLEM	PROBLEM	NN	B-NP	B-protein
#	#	#	I-NP	I-protein
7	7	CD	I-NP	I-protein
,	,	,	O	O
VASCULAR	VASCULAR	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
peripheral	peripheral	JJ	B-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
Vascular	Vascular	NNP	I-NP	O
Surgery	Surgery	NNP	I-NP	O
service	service	NN	I-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
to	to	TO	I-VP	O
help	help	VB	I-VP	O
manage	manage	VB	I-VP	O
refractory	refractory	JJ	B-NP	O
cellulitis	cellulitis	NN	I-NP	O
.	.	.	O	O

ABIs	ABI	NNS	B-NP	O
were	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
leg	leg	NN	I-NP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
0.5	0.5	CD	B-NP	O
to	to	TO	B-PP	O
0.6	0.6	CD	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
and	and	CC	O	O
normal	normal	JJ	B-ADJP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
which	which	WDT	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
previously	previously	RB	I-VP	O
bypassed	bypass	VBN	I-VP	O
.	.	.	O	O

Pulse	Pulse	NN	B-NP	O
volume	volume	NN	I-NP	O
recording	recording	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
mildly	mildly	RB	B-NP	O
decreased	decrease	VBN	I-NP	O
signal	signal	NN	I-NP	O
in	in	IN	B-PP	O
both	both	CC	B-NP	O
the	the	DT	I-NP	O
right	right	JJ	I-NP	O
and	and	CC	I-NP	O
left	left	JJ	I-NP	O
leg	leg	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
conclusion	conclusion	NN	I-NP	O
was	be	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
right	right	JJ	B-NP	O
femoral	femoral	JJ	I-NP	O
popliteal	popliteal	JJ	I-NP	O
disease	disease	NN	I-NP	O
with	with	IN	B-PP	O
normal	normal	JJ	B-NP	O
resting	rest	VBG	I-NP	O
pressures	pressure	NNS	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
left	left	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
very	very	RB	B-ADJP	O
mobile	mobile	JJ	I-ADJP	O
,	,	,	O	O
she	she	PRP	B-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
complain	complain	VB	I-VP	O
of	of	IN	B-PP	O
any	any	DT	B-NP	O
claudication	claudication	NN	I-NP	O
symptoms	symptom	NNS	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
decided	decide	VBN	I-VP	O
that	that	IN	B-SBAR	O
no	no	DT	B-NP	O
surgery	surgery	NN	I-NP	O
is	be	VBZ	B-VP	O
indicated	indicate	VBN	I-VP	O
for	for	IN	B-PP	O
her	her	PRP	B-NP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
used	use	VBD	B-VP	O
heparin	heparin	NN	B-NP	O
subcutaneous	subcutaneous	JJ	I-NP	O
injections	injection	NNS	I-NP	O
as	as	IN	B-PP	O
her	her	PRP$	B-NP	O
DVT	DVT	NN	I-NP	O
prophylaxis	prophylaxis	NN	I-NP	O
during	during	IN	B-PP	O
her	her	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

PROBLEM	PROBLEM	NN	B-NP	B-protein
#	#	#	B-NP	I-protein
8	8	CD	I-NP	I-protein
,	,	,	O	O
CONGESTIVE	CONGESTIVE	NNP	B-NP	O
HEART	HEART	NNP	I-NP	O
FAILURE	FAILURE	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
from	from	IN	B-PP	O
diastolic	diastolic	JJ	B-NP	O
dysfunction	dysfunction	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
examination	examination	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
1	1	CD	B-NP	O
+	+	SYM	I-NP	O
edema	edema	NN	I-NP	O
throughout	throughout	IN	B-PP	O
her	her	PRP$	B-NP	O
body	body	NN	I-NP	O
including	include	VBG	B-PP	O
her	her	PRP$	B-NP	O
upper	upper	JJ	I-NP	O
limbs	limb	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
chest	chest	NN	I-NP	O
area	area	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
attempts	attempt	VBZ	B-VP	O
at	at	IN	B-PP	O
diuresis	diuresis	NN	B-NP	O
were	be	VBD	B-VP	O
aborted	abort	VBN	I-VP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
acute	acute	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
diurese	diurese	VB	I-VP	O
on	on	IN	B-PP	O
her	her	PRP	B-NP	O
own	own	JJ	I-NP	O
without	without	IN	B-PP	O
any	any	DT	B-NP	O
pharmacologic	pharmacologic	JJ	I-NP	O
interventions	intervention	NNS	I-NP	O
,	,	,	O	O
as	as	IN	B-PP	O
her	her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
improved	improve	VBD	B-VP	O
.	.	.	O	O

At	At	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
her	her	PRP$	B-NP	O
Lasix	Lasix	NN	I-NP	O
is	be	VBZ	B-VP	O
held	hold	VBN	I-VP	O
because	because	IN	B-PP	O
of	of	IN	I-PP	O
a	a	DT	B-NP	O
small	small	JJ	I-NP	O
bump	bump	NN	I-NP	O
in	in	IN	B-PP	O
creatinine	creatinine	NN	B-NP	O
from	from	IN	B-PP	O
likely	likely	RB	B-ADJP	O
the	the	DT	B-NP	O
contrast	contrast	NN	I-NP	O
in	in	IN	B-PP	O
CT	CT	NN	B-NP	B-protein
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
enalapril	enalapril	NN	I-NP	O
.	.	.	O	O

Overall	Overall	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
total	total	JJ	B-NP	O
body	body	NN	I-NP	O
volume	volume	NN	I-NP	O
up	up	RB	B-ADVP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
much	much	RB	B-VP	O
improved	improve	VBN	I-VP	O
from	from	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

PROBLEM	PROBLEM	NN	B-NP	B-protein
#	#	#	B-NP	I-protein
9	9	CD	I-NP	I-protein
,	,	,	O	O
TYPE	TYPE	NN	B-NP	O
II	II	CD	I-NP	O
DIABETES	DIABETES	NNS	I-NP	O
MELLITUS	MELLITUS	NNS	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
blood	blood	NN	I-NP	O
sugars	sugar	NNS	I-NP	O
were	be	VBD	B-VP	O
poorly	poorly	RB	I-VP	O
controlled	control	VBN	I-VP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
with	with	IN	B-PP	O
finger	finger	NN	B-NP	O
sticks	stick	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
high	high	JJ	I-NP	O
100s	100s	CD	I-NP	O
to	to	TO	B-PP	O
low	low	JJ	B-NP	O
200s	200s	CD	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
partially	partially	RB	B-ADJP	O
due	due	JJ	I-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
reluctance	reluctance	NN	I-NP	O
to	to	TO	B-VP	O
take	take	VB	I-VP	O
her	her	PRP$	B-NP	O
full	full	JJ	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
NPH	NPH	NN	B-NP	B-protein
Insulin	Insulin	NN	I-NP	I-protein
because	because	IN	B-SBAR	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
inconsistent	inconsistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
eating	eat	VBG	B-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
sliding	slide	VBG	I-NP	O
scale	scale	NN	I-NP	O
to	to	TO	B-VP	O
cover	cover	VB	I-VP	O
her	her	PRP	B-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
will	will	MD	B-VP	O
encourage	encourage	VB	I-VP	O
her	her	PRP	B-NP	O
to	to	TO	B-VP	O
continue	continue	VB	I-VP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
full	full	JJ	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
Insulin	Insulin	NN	B-NP	B-protein
as	as	IN	B-SBAR	O
she	she	PRP	B-NP	O
tolerates	tolerate	VBZ	B-VP	O
food	food	NN	B-NP	O
better	better	RB	B-ADVP	O
.	.	.	O	O

PROBLEM	PROBLEM	NN	B-NP	O
#	#	#	B-NP	O
10	10	CD	I-NP	O
,	,	,	O	O
PERIPHERAL	PERIPHERAL	NNP	B-NP	O
NEUROPATHY	NEUROPATHY	NNP	I-NP	O
AND	AND	NNP	I-NP	O
LOW	LOW	NNP	I-NP	O
BACK	BACK	NNP	I-NP	O
PAIN	PAIN	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
Neurontin	Neurontin	NN	I-NP	O
dose	dose	NN	I-NP	O
was	be	VBD	B-VP	O
reduced	reduce	VBN	I-VP	O
to	to	TO	B-PP	O
100	100	CD	B-NP	O
mg	mg	NN	I-NP	O
t.i.d.	t.i.d.	RB	B-ADVP	O
from	from	IN	B-PP	O
her	her	PRP$	B-NP	O
outpatient	outpatient	NN	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
300	300	CD	B-NP	O
mg	mg	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
renal	renal	JJ	B-NP	O
insufficiency	insufficiency	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
received	receive	VBD	B-VP	O
Diazepam	Diazepam	NN	B-NP	O
currently	currently	RB	B-ADVP	O
at	at	IN	B-PP	O
2.5	2.5	CD	B-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
reduced	reduce	VBN	B-VP	O
from	from	IN	B-PP	O
her	her	PRP$	B-NP	O
outpatient	outpatient	NN	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
5.5	5.5	CD	B-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
because	because	IN	B-PP	O
of	of	IN	I-PP	O
renal	renal	JJ	B-NP	O
insufficiency	insufficiency	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
requires	require	VBZ	B-VP	O
morphine	morphine	NN	B-NP	O
sulfate	sulfate	NN	I-NP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
p.r.n.	p.r.n.	JJ	I-NP	O
basis	basis	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
pain	pain	NN	I-NP	O
control	control	NN	I-NP	O
is	be	VBZ	B-VP	O
satisfactory	satisfactory	JJ	B-ADJP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
dictation	dictation	NN	I-NP	O
.	.	.	O	O

Dictated	Dictate	VBN	B-VP	O
By	By	IN	B-PP	O
:	:	:	O	O
WILBER	WILBER	NNP	B-NP	O
BUCKBEE	BUCKBEE	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
YN2	YN2	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
HARRIS	HARRIS	NNP	B-NP	O
BERDECIA	BERDECIA	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
TC97	TC97	NNP	I-NP	O
TR830/8430	TR830/8430	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
4532	4532	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

ZPGT3LEPH7	ZPGT3LEPH7	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
3/9	3/9	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
3/9	3/9	CD	B-NP	O

